Search for: "HALOZYME, INC." Results 1 - 1 of 1
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Trastuzumab x recombinant human hyaluronidase: the French Supreme Court clarifies the interpretation of article 1 b) of the SPC Regulation
20 Feb 2023, 4:23 am by Matthieu Dhenne (Ipsilon)
In this case, Halozyme Inc. had applied for an SPC (FR15C0053) for a combination product of trastuzumab and recombinant human hyaluronidase on the basis of a marketing authorization (“MA”) granted on August 26, 2013. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/